Ionis Pharmaceuticals
IONS
IONS
307 hedge funds and large institutions have $4.93B invested in Ionis Pharmaceuticals in 2018 Q2 according to their latest regulatory filings, with 31 funds opening new positions, 111 increasing their positions, 94 reducing their positions, and 48 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
more funds holding in top 10
Funds holding in top 10: →
less capital invested
Capital invested by funds: $ → $
6% less funds holding
Funds holding: 325 → 307 (-18)
21% less call options, than puts
Call options by funds: $45.1M | Put options by funds: $56.9M
35% less first-time investments, than exits
New positions opened: 31 | Existing positions closed: 48
Holders
307
Holding in Top 10
4
Calls
$45.1M
Puts
$56.9M
Top Buyers
| 1 | +$126M | |
| 2 | +$23.8M | |
| 3 | +$23.3M | |
| 4 |
FLAM
First Light Asset Management
Edina,
Minnesota
|
+$18.8M |
| 5 |
PCM
Peregrine Capital Management
Minneapolis,
Minnesota
|
+$13.6M |
Top Sellers
| 1 | -$29.4M | |
| 2 | -$14.8M | |
| 3 | -$13.8M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$12.3M |
| 5 |
Goldman Sachs
New York
|
-$12.1M |